These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17728291)

  • 1. Economic analysis and complex randomized controlled trials.
    Delaney B
    Fam Pract; 2007 Sep; 24(4):293-4. PubMed ID: 17728291
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials and health economics--a marriage of convenience or a marriage made in heaven?
    Bakhai A; Greenberg D
    J Med Econ; 2008; 11(3):541-6. PubMed ID: 19450103
    [No Abstract]   [Full Text] [Related]  

  • 3. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Role of economic models in randomized clinical trials.
    Hlatky MA
    Am Heart J; 1999 May; 137(5):S41-6. PubMed ID: 10220595
    [No Abstract]   [Full Text] [Related]  

  • 4. Raising the standards of trial-based economic evaluation: the devil is in the detail.
    Backhouse ME
    Value Health; 2005; 8(5):519-20. PubMed ID: 16176490
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacoeconomics: integrating economic evaluation into clinical trials.
    Haycox A; Drummond M; Walley T
    Br J Clin Pharmacol; 1997 Jun; 43(6):559-62. PubMed ID: 9205814
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcomes, costs, and policy caution. A commentary on: the Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
    Rosenheck RA
    Arch Gen Psychiatry; 2006 Oct; 63(10):1074-6. PubMed ID: 17015809
    [No Abstract]   [Full Text] [Related]  

  • 7. A framework for cost-effectiveness analysis from clinical trial data.
    O'Hagan A; Stevens JW
    Health Econ; 2001 Jun; 10(4):303-15. PubMed ID: 11400253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grading systems for cost-effectiveness studies: is the whole greater than the sum of the parts?
    Stearns SC; Drummond M
    Med Care; 2003 Jan; 41(1):1-3. PubMed ID: 12544536
    [No Abstract]   [Full Text] [Related]  

  • 9. Are systematic reviews more cost-effective than randomised trials?
    Glasziou P; Djulbegovic B; Burls A
    Lancet; 2006 Jun; 367(9528):2057-8. PubMed ID: 16798380
    [No Abstract]   [Full Text] [Related]  

  • 10. Two-level resampling as a novel method for the calculation of the expected value of sample information in economic trials.
    Sadatsafavi M; Marra C; Bryan S
    Health Econ; 2013 Jul; 22(7):877-82. PubMed ID: 22933363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian cost-effectiveness analysis from clinical trial data.
    O'Hagan A; Stevens JW; Montmartin J
    Stat Med; 2001 Mar; 20(5):733-53. PubMed ID: 11241573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation and clinical trials: size matters.
    Briggs A
    BMJ; 2000 Dec; 321(7273):1362-3. PubMed ID: 11099268
    [No Abstract]   [Full Text] [Related]  

  • 13. Generalisation from phase III clinical trials: survival, quality of life, and health economics.
    Fayers PM; Hand DJ
    Lancet; 1997 Oct; 350(9083):1025-7. PubMed ID: 9329528
    [No Abstract]   [Full Text] [Related]  

  • 14. From efficacy to cost-effectiveness.
    Thompson S; Barber J
    Lancet; 1997 Dec; 350(9093):1781-2. PubMed ID: 9413495
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models.
    Manca A; Rice N; Sculpher MJ; Briggs AH
    Health Econ; 2005 May; 14(5):471-85. PubMed ID: 15386662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002.
    Chalmers I; Rounding C; Lock K
    BMJ; 2003 Nov; 327(7422):1017. PubMed ID: 14593034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction.
    Evid Based Med; 2015 Aug; 20(4):123. PubMed ID: 26209721
    [No Abstract]   [Full Text] [Related]  

  • 18. Adding cost to number needed to treat: the COPE statistic.
    Maharaj R
    Evid Based Med; 2007 Aug; 12(4):101-2. PubMed ID: 17885150
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomization within quality registries: a cost-effective complement to classical randomized trials.
    Eur Heart J; 2014 Jan; 35(1):1-2. PubMed ID: 24382633
    [No Abstract]   [Full Text] [Related]  

  • 20. Switching therapy in health economics trials: confronting the confusion.
    Torrance GW; Drummond MF; Walker V
    Med Decis Making; 2003; 23(4):335-40. PubMed ID: 12926583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.